Hospital General Universitario De Ciudad Real
- Address
- lock Available on a paid plan
Cardiovascular Research at Hospital General Universitario De Ciudad Real
This site is active in cardiovascular diseases, with studies focused on conditions such as transthyretin cardiac amyloidosis, spontaneous coronary artery dissection, and genetic carriers of dilated cardiomyopathy. The trials are designed to assess whether new or optimized treatments can better protect heart function and improve outcomes in people at risk of heart failure or acute coronary events.
- Evaluating heart function in transthyretin cardiac amyloidosis
- Testing early treatment to prevent dilated cardiomyopathy progression
- Studying medical therapy for spontaneous coronary artery dissection
- Improving cardiovascular prevention in inflammatory rheumatic disease
This research reflects a strong interest in both treatment effectiveness and early prevention strategies in cardiology.
Kidney and Immune-Mediated Disease Studies
Clinical trials at this Spanish hospital also address immune system diseases and renal disorders, including lupus nephritis and immunoglobulin A nephropathy. These studies aim to improve kidney response, reduce disease flares, and identify better options for patients with active autoimmune-related kidney disease.
- Assessing new therapies for lupus nephritis
- Comparing treatment approaches in proliferative kidney inflammation
- Evaluating renal response and flare prevention
The work in nephrology and immunology is centered on finding more effective ways to control chronic inflammatory kidney disease.
Oncology and Surgical Treatment Research
The site is involved in neoplasms research across several cancers, including metastatic castration-resistant prostate cancer, upper tract urothelial carcinoma, anal canal squamous cell carcinoma, and peritoneal metastases of colorectal cancer. These trials are exploring whether new drug combinations, radioligand therapy, or surgical strategies can improve cancer control and reduce recurrence.
- Testing advanced treatment for metastatic prostate cancer
- Studying chemotherapy planning in upper tract urothelial carcinoma
- Evaluating combined therapy for anal cancer
- Assessing recurrence prevention in colorectal cancer spread to the peritoneum
This area highlights a broad effort to refine both systemic and local approaches in oncology.
Respiratory and Critical Care Trials
Research in respiratory tract diseases and acute care includes studies in acute respiratory distress syndrome and septic shock. The main purpose is to determine whether targeted resuscitation or new therapies can improve survival, reduce the need for ventilation, and support recovery in critically ill patients.
- Investigating treatment for acute respiratory distress syndrome
- Testing resuscitation strategies in septic shock
- Improving outcomes in intensive care patients
These trials show a clear focus on critical care medicine and better management of life-threatening conditions.
Allergy, Skin, and Musculoskeletal Research
The trial portfolio also includes skin and connective tissue diseases, musculoskeletal diseases, and selected allergic conditions. Studies are examining improved symptom control for allergic rhinitis, better field treatment for actinic keratoses, and stronger prevention of fractures in older women with bone fragility.
- Evaluating allergy treatment for rhinitis and related asthma
- Studying topical therapy for actinic keratoses
- Comparing treatments to prevent vertebral fractures
This mix of studies combines dermatology, allergy, and bone health research aimed at improving everyday quality of life and reducing future complications.
Anesthesia and Procedure-Related Research
The site also contributes to anesthesia and analgesia research, with work focused on general anesthesia in adults undergoing surgery. These trials are intended to compare approaches that may support safer induction and more reliable perioperative care.
- Assessing methods for anesthesia induction
- Comparing options to support surgical care
- Improving safety in elective procedures
This area adds an important procedural dimension to the broader clinical research program at Hospital General Universitario De Ciudad Real.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 13 therapeutic areas and 15 of 59 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 48 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 9 by active trials.
- 1Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda2active
lock +8 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital General Universitario De Ciudad Real
lock Showing 1 of 17 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of [177Lu]LU-PSMA-I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer | Curium Pet France | Phase III | Not Recruiting | Feb 2023 | — |
IMP list
lock Showing 1 of 59 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Prednisone | 2 | Unknown | 2023-02-16 | 2023-02-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
